NO20054533D0 - Oral insulinsammensetning og metoder for a lage og bruke den - Google Patents

Oral insulinsammensetning og metoder for a lage og bruke den

Info

Publication number
NO20054533D0
NO20054533D0 NO20054533A NO20054533A NO20054533D0 NO 20054533 D0 NO20054533 D0 NO 20054533D0 NO 20054533 A NO20054533 A NO 20054533A NO 20054533 A NO20054533 A NO 20054533A NO 20054533 D0 NO20054533 D0 NO 20054533D0
Authority
NO
Norway
Prior art keywords
making
methods
oral insulin
insulin composition
composition
Prior art date
Application number
NO20054533A
Other languages
English (en)
Other versions
NO20054533L (no
Inventor
Vladimir Sabetsky
Original Assignee
Technology Dev Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technology Dev Company Ltd filed Critical Technology Dev Company Ltd
Publication of NO20054533D0 publication Critical patent/NO20054533D0/no
Publication of NO20054533L publication Critical patent/NO20054533L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
NO20054533A 2003-03-04 2005-10-03 Oral insulinsammensetning og metoder for a lage og bruke den NO20054533L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US45124503P 2003-03-04 2003-03-04
US46760103P 2003-05-05 2003-05-05
US46901703P 2003-05-09 2003-05-09
US49509703P 2003-08-15 2003-08-15
PCT/IB2004/000933 WO2004078196A1 (en) 2003-03-04 2004-03-04 Oral insulin composition and methods of making and using thereof

Publications (2)

Publication Number Publication Date
NO20054533D0 true NO20054533D0 (no) 2005-10-03
NO20054533L NO20054533L (no) 2005-12-02

Family

ID=32831112

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20054534A NO20054534L (no) 2003-03-04 2005-10-03 Leveringssystem for legemiddel og celleterapi
NO20054533A NO20054533L (no) 2003-03-04 2005-10-03 Oral insulinsammensetning og metoder for a lage og bruke den
NO20054539A NO20054539L (no) 2003-03-04 2005-10-03 Langtidsvirkende injekterbar insulinpreparat og fremgangsmate for fremstilling og anvendelse derav

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20054534A NO20054534L (no) 2003-03-04 2005-10-03 Leveringssystem for legemiddel og celleterapi

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20054539A NO20054539L (no) 2003-03-04 2005-10-03 Langtidsvirkende injekterbar insulinpreparat og fremgangsmate for fremstilling og anvendelse derav

Country Status (17)

Country Link
US (5) US20040234615A1 (no)
EP (3) EP1603589A1 (no)
JP (3) JP2006519840A (no)
KR (3) KR20060015469A (no)
AR (1) AR046485A1 (no)
AT (1) ATE485051T1 (no)
AU (3) AU2004216909A1 (no)
BR (3) BRPI0408105A (no)
CA (3) CA2518136A1 (no)
DE (1) DE602004029630D1 (no)
EA (3) EA200501422A1 (no)
EC (3) ECSP056076A (no)
MX (1) MXPA05009493A (no)
NO (3) NO20054534L (no)
PT (1) PT1454630E (no)
TW (1) TW200529869A (no)
WO (3) WO2004078196A1 (no)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7339033B2 (en) * 1998-06-26 2008-03-04 Genentech, Inc. Pro1481
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
SI1494732T1 (sl) 2002-03-20 2008-08-31 Mannking Corp Inhalacijski aparat
WO2004078196A1 (en) * 2003-03-04 2004-09-16 The Technology Development Company Ltd. Oral insulin composition and methods of making and using thereof
JP4463814B2 (ja) 2003-08-05 2010-05-19 ノボ ノルディスク アクティーゼルスカブ 新規のインスリン誘導体
TW200603843A (en) * 2004-04-20 2006-02-01 Technology Dev Company Ltd Tissue enhancement implant and method
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
US7820676B2 (en) 2004-08-23 2010-10-26 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
FR2880272A1 (fr) * 2005-01-04 2006-07-07 Jean Marc Ruiz Preparation contenant des microparticules d'un sel de polymere insoluble portant un principe actif, ainsi que son procede de fabrication
CA2621786A1 (en) * 2005-08-29 2007-03-08 Tuo Jin Polysaccharide microparticles containing biological agents: there preparation and applications
CA2621806C (en) 2005-09-14 2016-08-02 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
CN101389650B (zh) 2005-12-28 2012-10-10 诺沃-诺迪斯克有限公司 包含酰化胰岛素和锌的组合物以及制备所述组合物的方法
SE529040C2 (sv) * 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin
RU2403059C2 (ru) 2006-02-22 2010-11-10 Маннкайнд Корпорейшн Способ улучшения фармацевтических свойств микрочастиц, содержащих дикетопиперазин и активный агент
EP2069062A2 (en) * 2006-10-06 2009-06-17 The President and Fellows of Harvard College Chemically-directed electrostatic self-assembly of materials
ES2744384T3 (es) 2007-06-13 2020-02-24 Novo Nordisk As Formulación farmacéutica que comprende un derivado de insulina
EP2025334A1 (en) * 2007-07-25 2009-02-18 OctoPlus Sciences B.V. Sustained release drug delivery system for repeated administration
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CA3086027C (en) 2008-06-13 2022-05-17 Mannkind Corporation A dry powder inhaler and system for drug delivery
RU2470681C2 (ru) 2008-06-20 2012-12-27 Маннкайнд Корпорейшн Интерактивное устройство и способ профилирования усилий при ингаляции в реальном масштабе времени
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
FR2940802A1 (fr) * 2008-10-10 2010-07-09 Adocia Complexe entre l'insuline humaine et un polymere amphiphile et utilisation de ce complexe pour la preparation d'une formulation d'insuline humaine rapide.
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
BRPI0919946A2 (pt) * 2008-10-30 2016-02-16 Novo Nordisk As tratamento de diabetes melito usando injeções de insulina com frequência de injeção menor que diariamente
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2676695A3 (en) 2009-03-11 2017-03-01 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
FR2943538B1 (fr) * 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
KR20210027546A (ko) 2009-06-12 2021-03-10 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
US9068182B2 (en) * 2009-07-28 2015-06-30 Corning Incorporated Synthetic polysaccharide microcarriers for culturing cells
HUP0900482A2 (en) 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
US10029011B2 (en) 2009-11-13 2018-07-24 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine
PT2498801T (pt) 2009-11-13 2018-05-02 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendin-4(1-39)-lys6-nh2 e metionina
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
SG187904A1 (en) 2010-08-30 2013-04-30 Sanofi Aventis Deutschland Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
DK2632478T3 (da) 2010-10-27 2019-10-07 Novo Nordisk As Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller
EP2694402B1 (en) 2011-04-01 2017-03-22 MannKind Corporation Blister package for pharmaceutical cartridges
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012293312A1 (en) * 2011-08-07 2014-06-05 Transgene Biotek Ltd A novel method for peroral delivery of insulin and its analogues for therapeutic usage
KR101983982B1 (ko) 2011-08-29 2019-05-30 사노피-아벤티스 도이칠란트 게엠베하 2형 당뇨병 환자의 혈당 조절에 사용하기 위한 약제학적 병용물
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
CN103945859A (zh) 2011-10-24 2014-07-23 曼金德公司 用于治疗疼痛的方法和组合物
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
CN104619369B (zh) 2012-07-12 2018-01-30 曼金德公司 干粉药物输送系统和方法
US9157939B2 (en) * 2012-08-09 2015-10-13 Infineon Technologies Ag System and device for determining electric voltages
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
EA034393B1 (ru) 2012-11-13 2020-02-03 Адосиа Состав инсулина быстрого действия, содержащий замещенное анионное соединение
JP6523247B2 (ja) 2013-03-15 2019-05-29 マンカインド コーポレイション 微結晶性ジケトピペラジン粒子の製造方法および乾燥粉末組成物の製造方法
JP6457484B2 (ja) 2013-04-03 2019-01-23 サノフイＳａｎｏｆｉ インスリンの長時間作用型製剤による糖尿病の治療
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
JP6200698B2 (ja) * 2013-06-18 2017-09-20 ニュートリー株式会社 嚥下造影検査食
KR102321339B1 (ko) 2013-07-18 2021-11-02 맨카인드 코포레이션 열-안정성 건조 분말 약제학적 조성물 및 방법
WO2015021064A1 (en) 2013-08-05 2015-02-12 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
RU2014120626A (ru) * 2014-05-22 2015-11-27 Владимир Андреевич Сабецкий Инсулинсодержащий препарат пролонгированного действия
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN105617362B (zh) * 2014-10-27 2021-05-11 中国医学科学院药物研究所 一种新型的胰岛素－磷脂－壳聚糖自组装微粒载体及其制剂
NZ733670A (en) 2014-12-12 2021-12-24 Sanofi Aventis Deutschland Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
WO2017141262A1 (en) 2016-02-19 2017-08-24 Indian Institute Of Technology, Bombay Orally administrable pharmaceutical preparation containing protein
RU2647466C1 (ru) * 2016-12-01 2018-03-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный университет" (СПбГУ) Способ получения нативного белка пролонгирующего действия в составе полимерных наносфер и резорбируемых микросфер для доставки
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
KR20200056360A (ko) 2020-04-29 2020-05-22 김용원 자전거바퀴(회전자)와 바퀴덮개(고정자)에 설치하는 발전기
KR20200056359A (ko) 2020-04-29 2020-05-22 김용원 퀵보드 등 승용기구바퀴(회전자)에 설치되는 바퀴덮개(고정자)에 설치하는 발전기
KR20200056361A (ko) 2020-05-04 2020-05-22 김용원 발판보드에 설치하는 발전기
KR20200060307A (ko) 2020-05-06 2020-05-29 김용원 자전거와 리어 캐리어에 설치하는 발전장치들
KR20200060308A (ko) 2020-05-07 2020-05-29 김용원 수상보드에 설치하는 발전기
KR20200060309A (ko) 2020-05-08 2020-05-29 김용원 헬스차량에 설치하는 발전기
KR20200061324A (ko) 2020-05-11 2020-06-02 김용원 보트에 설치하는 발전기
KR20200062092A (ko) 2020-05-11 2020-06-03 김용원 수차와 공기 컴프레서를 이용한 공기 터빈구조 발전기와 바퀴구조 발전기를 합한 발전기
KR20200068614A (ko) 2020-05-26 2020-06-15 김용원 펠티어소자를 이용한 공기, 물 컨디션너 조절장치 내에 설치한 발전기
KR20200083393A (ko) 2020-06-16 2020-07-08 김용원 "공기 터빈구조 발전기"와 "바퀴구조를 합한 발전기"를 "발열소자를 이용한 발전기"와 적용 양방향 모터(양방향 프로펠러)를 양방향공기추진기(Propullor)와 결합 장착한 드론
KR20200088241A (ko) 2020-06-30 2020-07-22 김용원 역방향 모터(양방향 프로펠러)의 추진에 맞는 관성을 이기는 팬이 없는 양방향공기추진기(Propullor)를 장착한 드론
KR20200108392A (ko) 2020-08-31 2020-09-18 김용원 전동 오토바이 모터의 정격에 맞는 오토바이바퀴에 회전자와 물받이 고정자 발전기를 설치한 오토바이에 모터가 장착된 항공기 공기추진기(Propulsor)와 장착한 드론의 프로퓰러(Propullor)를 장착하는 제조기술)
KR20210018367A (ko) 2021-01-26 2021-02-17 김용원 전동 오토바이에 설치한 모터가 장착된 항공기 공기추진기와 장착한 프로퓰러(Propullor)로 구성한 오토에어크라프트(Autoaircraft)
KR20210029730A (ko) 2021-02-22 2021-03-16 김용원 산사태에 대비, 대응하는 에어 레이어들 블록들이 형성된 거대장비들(에어 레이어들 블록들)
KR20210040852A (ko) 2021-03-24 2021-04-14 김용원 전동에어버스
KR20210043513A (ko) 2021-03-26 2021-04-21 김용원 전동에어버스에 설치하는 연기(분연), 재 포집장치
KR20210045369A (ko) 2021-03-31 2021-04-26 김용원 전기 에어 카
KR20210049046A (ko) 2021-04-13 2021-05-04 김용원 전기에어버스를 강풍, 태풍에 구조하는 보조날개와 보조출입문 장치
KR20210055643A (ko) 2021-04-27 2021-05-17 김용원 모터가 장착된 회전축에 다량의 회전자바퀴와 다량의 고정자바퀴발전기를 설치한 전동보드
KR20210072739A (ko) 2021-05-27 2021-06-17 김용원 의료용 전동보드
KR20210080293A (ko) 2021-06-11 2021-06-30 김용원 바퀴 사이 발전기 케이스
CN115702880B (zh) * 2021-08-12 2023-11-03 山东新时代药业有限公司 一种重组甘精胰岛素注射液及其制备工艺
KR20220016234A (ko) 2022-01-14 2022-02-08 김용원 공기추진기(공기펌프와 공기터빈)를 장착한 3륜 자전거
KR20220038026A (ko) 2022-02-24 2022-03-25 김용원 4합 공기터빈 : 공기터빈 축에 1. 인너 팬들의 인너 실린더와 2. 아웃터 팬들의 아웃터 실린더와 3. 양쪽 1. 인너 실린더들과 2. 아웃터 실린더들의 사이에 아웃터 팬들에 덕트팬들과 덕트흡입구와 4 1. 인너 실린더들과 2. 아웃터 실린더들의 사이에 아웃터 팬들의 3. 덕트팬들에 블레이드와 블레이드 외부 형틀
KR20220056159A (ko) 2022-04-04 2022-05-04 김용원 물탱크 내의 스팀집 슈퍼히터에 전력공급한 스팀공급으로 스팀터빈을 구동하는 것과 슈퍼히터로 스팀을 공급하는 스팀청소기에 발전기들을 설치하는 것과 공기터빈의 흡입구들의 공기필터들 설치와 펠티에소자를 이용한 냉온 공기배출과 얼음제조기 시스템
KR20220056835A (ko) 2022-04-18 2022-05-06 김용원 공기추진기(공기펌프와 여러 공기터빈들)들을 장착한 수상 자전거
KR20220076421A (ko) 2022-05-11 2022-06-08 김용원 공기추진기(공기펌프와 공기터빈들)들을 장착한 페달자전차
KR20220080053A (ko) 2022-05-27 2022-06-14 김용원 다중 에어 레이어 튜브보트

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713249A (en) 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
SE8204244L (sv) * 1982-07-09 1984-01-10 Ulf Schroder Kristalliserad kolhydratsmatris for biologiskt aktiva substanser
US4963526A (en) * 1984-05-09 1990-10-16 Synthetic Blood Corporation Oral insulin and a method of making the same
WO1987002704A1 (en) 1985-10-22 1987-05-07 Eric Robinson Process for cell immobilisation
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
USRE37950E1 (en) 1990-04-24 2002-12-31 Atrix Laboratories Biogradable in-situ forming implants and methods of producing the same
US5618531A (en) 1990-10-19 1997-04-08 New York University Method for increasing the viability of cells which are administered to the brain or spinal cord
US5840290A (en) * 1996-05-30 1998-11-24 University Of Florida Research Foundation Injectable bio-active glass in a dextran suspension
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
ATE322890T1 (de) 1996-11-19 2006-04-15 Octoplus B V Verfahren zur herstellung eines systems mit gesteuerter freisetzung
US6395302B1 (en) * 1996-11-19 2002-05-28 Octoplus B.V. Method for the preparation of microspheres which contain colloidal systems
EP0842657A1 (en) 1996-11-19 1998-05-20 OctoPlus B.V. Microspheres for controlled release and processes to prepare these microspheres
FR2764514B1 (fr) * 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
JP2001509419A (ja) 1997-07-10 2001-07-24 ユーエスバイオマテリアルズ コーポレイション 成形可能な生物活性組成物
US6194006B1 (en) * 1998-12-30 2001-02-27 Alkermes Controlled Therapeutics Inc. Ii Preparation of microparticles having a selected release profile
US20020054914A1 (en) 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
ATE264669T1 (de) * 1999-02-19 2004-05-15 Univ Utrecht Stereokomplexe hydrogele
FR2794649B1 (fr) * 1999-06-11 2003-04-11 Solutions Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
EP1220909A2 (en) * 1999-09-27 2002-07-10 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
EP1184032A1 (en) * 2000-08-31 2002-03-06 OctoPlus B.V. Dextran hydrogels
FR2814951B1 (fr) * 2000-10-06 2003-01-17 Flamel Tech Sa Suspension colloidale de particules submicroniques de vectorisation de principes actifs hydrophiles (insuline) et leur mode de preparation
EP1333814A1 (en) * 2000-11-16 2003-08-13 Jagotec Ag Parenterally administrable microparticles
WO2002067995A1 (en) 2001-02-26 2002-09-06 Council Of Scientific And Industrial Research Carrier systems comprising vitamin b12 - biodegradable micro particulate conju gates for peroral delivery of drugs, peptides/proteins and vaccines
EP1270012A1 (en) * 2001-06-21 2003-01-02 Pfizer Products Inc. Use of pulmonary administration of insulin for treatment of diabetes
WO2004078196A1 (en) * 2003-03-04 2004-09-16 The Technology Development Company Ltd. Oral insulin composition and methods of making and using thereof
SE529040C2 (sv) * 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin

Also Published As

Publication number Publication date
DE602004029630D1 (de) 2010-12-02
KR20060015469A (ko) 2006-02-17
US7544656B2 (en) 2009-06-09
MXPA05009493A (es) 2006-08-11
WO2004078196A1 (en) 2004-09-16
ATE485051T1 (de) 2010-11-15
CA2518143A1 (en) 2004-09-16
JP2006519840A (ja) 2006-08-31
CA2518148A1 (en) 2004-09-16
AU2004216911A1 (en) 2004-09-16
KR20060014027A (ko) 2006-02-14
WO2004078197A1 (en) 2004-09-16
PT1454630E (pt) 2010-12-15
ECSP056077A (es) 2006-08-30
US20040234615A1 (en) 2004-11-25
KR20060015472A (ko) 2006-02-17
EP1454630B1 (en) 2010-10-20
BRPI0408105A (pt) 2006-03-01
EP1454630A1 (en) 2004-09-08
NO20054534L (no) 2005-11-29
NO20054539L (no) 2005-12-01
JP2006519253A (ja) 2006-08-24
BRPI0408097A (pt) 2006-02-14
EP1603589A1 (en) 2005-12-14
US20040234616A1 (en) 2004-11-25
ECSP056076A (es) 2006-08-30
AR046485A1 (es) 2005-12-14
AU2004216909A1 (en) 2004-09-16
CA2518136A1 (en) 2004-09-16
NO20054533L (no) 2005-12-02
EA200501422A1 (ru) 2006-04-28
WO2004078198A1 (en) 2004-09-16
AU2004216908A1 (en) 2004-09-16
ECSP056078A (es) 2006-08-30
US20100167985A1 (en) 2010-07-01
EA200501420A1 (ru) 2006-04-28
NO20054539D0 (no) 2005-10-03
US20100166855A1 (en) 2010-07-01
BRPI0408100A (pt) 2006-03-01
TW200529869A (en) 2005-09-16
JP2006519252A (ja) 2006-08-24
US20110097385A1 (en) 2011-04-28
EA200501421A1 (ru) 2006-04-28
EP1454631A1 (en) 2004-09-08
NO20054534D0 (no) 2005-10-03

Similar Documents

Publication Publication Date Title
NO20054533D0 (no) Oral insulinsammensetning og metoder for a lage og bruke den
NO20054220D0 (no) Substituerte N-arylheterocykler, fremgangsmate for fremstilling derav og deres anvendelse som legemiddel
NO20055633D0 (no) Oralt snusprodukt og fremgangsmate for a fremstille snusproduktet
TWI365064B (en) Oral care implement
HK1082392A1 (zh) 口腔護理工具
HK1106987A1 (en) Oral care implement
NO20034465D0 (no) Medisinsk pasientsimulator
DE602004017381D1 (de) Zweiteilige selbstklebende Dentalmassen
ATE389374T1 (de) Zwischenwirbelimplantat
NO20055211D0 (no) Anti-fungale forbindelser og fremgangsmater for anvendelse
TWI371251B (en) Oral care implement
DK1898829T3 (da) Fremgangsmåde til fremstilling af en tandprotesedel og således fremstillet tandprotesedel
NO20044136L (no) Anordning for aktivering av et bronnverktoy og fremgangsmate for bruk av den samme
DK1713544T3 (da) Sammensætninger og fremgangsmåder til oral og personlig pleje
DE602004014132D1 (de) Interdentalbürste und herstellungsverfahren dafür
DK1702917T3 (da) Amidderivat og medicin
DK1638502T3 (da) Dentalt behandlingselement
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
IS8489A (is) Umritunarstillar og aðferðir þeirra
ITMI20032618A1 (it) Impianto dentale
GB0413022D0 (en) Medical teaching aid
SE0303324L (sv) Implantat
DK2067779T3 (da) Tiotropiumsalte, fremgangsmåde til deres fremstilling og lægemiddelformuleringer indeholdende disse
DK1965868T3 (da) Peroxidfri tilberedning til blegning af naturlige og kunstige tænder
DE502004000390D1 (de) Härtbare Dentalmassen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application